ArticleCommunications chemistry2026
CholBindNet as an interpretable neural network for cholesterol-binding site classification.
Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Docking-score landscapes shape active-learning performance across Vina, Glide, and SILCS.Journal of computer-aided molecular design · 2026Article
- Article
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Cholesterol is a key modulator of membrane protein structure and function, yet predicting cholesterol-binding sites remains challenging due to its non-druglike physicochemical properties. Here, we curated more than 800 high-resolution transmembrane protein structures containing cholesterol, and developed an interpretable, atom-based graph neural network, called CholBindNet. A positive-unlabeled (PU) training strategy was employed to address the scarcity of negative samples due to the promiscuous nature of cholesterol binding. We show that CholBindNet substantially outperforms existing machine learning models trained on general ligand-binding datasets, including AlphaFold3, P2Rank, and DiffDock. The performance and generalizability of the model on unseen membrane proteins were further demonstrated by rapidly assessing cholesterol-binding sites in the PIEZO2 ion channel against all-atom molecular dynamics (MD) simulations conducted on Anton3 supercomputer. Additionally, strong model interpretability was achieved for CholBindNet through atom-level feature encoding, Grad-CAM visualization, and attention-based scoring analysis. Overall, CholBindNet provides an efficient and scalable approach for classifying and ranking cholesterol-binding sites on membrane proteins, achieving performance comparable to computationally expensive MD simulations while offering rich biophysical insights into the atomic-level spatial patterns beyond amino-acid sequence. This work lays the foundation for future deep-learning models targeting membrane protein drug-binding sites and cholesterol-modulated therapeutics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.